BioSpace News Archive

Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it will release its fourth quarter and full-year 2021 financial results after market close on Wednesday, March 16, 2022.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), today announced the listing of the Flamingo-01 Phase III trial on clinicaltrials.gov provides clinicians and patients with an important source of information including trial updates and design, participating clinical sites, and contact information.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced plans to establish an Enterprise Solutions Hub in Atlanta, Georgia.

MiNK Therapeutics, announced that it has begun dosing patients with solid tumor cancers with AgenT-797 alone and in combination with approved anti-PD-1 checkpoint inhibitors in a Phase 1 open-label clinical trial.

DUBAI, United Arab Emirates, The global Protein Expression Technology Market is projected to experience significant growth during the forecast period, due to the growing demand for proteomics for the identification of several proteins that help in drug discovery, diseases diagnosis, and development of target-specific drugs.

DUBAI, United Arab Emirates, Rising prevalence of chronic obstructive pulmonary disease and obstructive sleep apnea has been increasing the demand for respiratory devices.

Albany NY, United States: The global market for fluid warmer devices has been rising on account of advancements in the field of surgical procedures.

BeiGene Announces Health Canada Approval for BRUKINSA ® (zanubrutinib) in Relapsed or Refractory Marginal Zone Lymphoma.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), leaders in the science of lung health, announced today that New York State Department of Health (NYSDOH) has given conditional approval to its diagnostic testing partner, KSL Diagnostics, Inc. in Buffalo NY, for the EXACT COVID-19 Antibody Test.

Citius Pharmaceuticals, Inc. announced that it will be presenting at two investor conferences in March 2022.